Nisa Investment Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $26M | Buy |
58,183
+1,589
| +3% | +$741K | 0.1% | 133 |
|
|
2025
Q4 | $25.7M | Buy |
56,594
+816
| +1% | +$352K | 0.08% | 141 |
|
|
2025
Q3 | $21.8M | Sell |
55,778
-9,639
| -15% | -$4.03M | 0.08% | 154 |
|
|
2025
Q2 | $29.1M | Sell |
65,417
-2,883
| -4% | -$1.33M | 0.13% | 118 |
|
|
2025
Q1 | $33.1M | Sell |
68,300
-1,922
| -3% | -$896K | 0.17% | 111 |
|
|
2024
Q4 | $28.3M | Sell |
70,222
-5,128
| -7% | -$2.38M | 0.11% | 146 |
|
|
2024
Q3 | $35M | Buy |
75,350
+2,221
| +3% | +$1.07M | 0.21% | 102 |
|
|
2024
Q2 | $34.3M | Buy |
73,129
+2,662
| +4% | +$1.16M | 0.22% | 92 |
|
|
2024
Q1 | $29.5M | Sell |
70,467
-6,158
| -8% | -$2.6M | 0.19% | 114 |
|
|
2023
Q4 | $31.2M | Sell |
76,625
-222
| -0.3% | -$82K | 0.22% | 99 |
|
|
2023
Q3 | $26.7M | Sell |
76,847
-2,875
| -4% | -$1.01M | 0.2% | 113 |
|
|
2023
Q2 | $28.1M | Sell |
79,722
-1,733
| -2% | -$584K | 0.21% | 109 |
|
|
2023
Q1 | $25.7M | Buy |
81,455
+1,925
| +2% | +$577K | 0.2% | 118 |
|
|
2022
Q4 | $23M | Sell |
79,530
-1,550
| -2% | -$472K | 0.18% | 133 |
|
|
2022
Q3 | $23.5M | Buy |
81,080
+4,999
| +7% | +$1.44M | 0.2% | 109 |
|
|
2022
Q2 | $21.4M | Buy |
76,081
+1,014
| +1% | +$271K | 0.19% | 119 |
|
|
2022
Q1 | $19.6M | Sell |
75,067
-10,995
| -13% | -$2.61M | 0.14% | 146 |
|
|
2021
Q4 | $20.9M | Sell |
86,062
-5,652
| -6% | -$1.1M | 0.16% | 142 |
|
|
2021
Q3 | $16.6K | Sell |
91,714
-11,072
| -11% | -$2.16M | 0.1% | 186 |
|
|
2021
Q2 | $20.7K | Buy |
102,786
+2,312
| +2% | +$484K | 0.13% | 154 |
|
|
2021
Q1 | $21.6K | Buy |
100,474
+440
| +0.4% | +$96.6K | 0.14% | 143 |
|
|
2020
Q4 | $23.6M | Sell |
100,034
-4,768
| -5% | -$1.09M | 0.15% | 151 |
|
|
2020
Q3 | $28.5M | Sell |
104,802
-25,566
| -20% | -$7.05M | 0.23% | 99 |
|
|
2020
Q2 | $37.8M | Buy |
130,368
+18,646
| +17% | +$5.06M | 0.35% | 64 |
|
|
2020
Q1 | $26.6M | Buy |
111,722
+8,217
| +8% | +$1.88M | 0.3% | 77 |
|
|
2019
Q4 | $22.7M | Buy |
103,505
+8,288
| +9% | +$1.68M | 0.19% | 118 |
|
|
2019
Q3 | $16.1M | Sell |
95,217
-6,053
| -6% | -$1.07M | 0.14% | 156 |
|
|
2019
Q2 | $18.6M | Sell |
101,270
-4,863
| -5% | -$850K | 0.18% | 122 |
|
|
2019
Q1 | $19.5M | Buy |
106,133
+3,380
| +3% | +$624K | 0.19% | 116 |
|
|
2018
Q4 | $17M | Sell |
102,753
-2,601
| -2% | -$451K | 0.19% | 123 |
|
|
2018
Q3 | $20.3M | Buy |
105,354
+13,117
| +14% | +$2.34M | 0.19% | 125 |
|
|
2018
Q2 | $15.7M | Buy |
92,237
+1,654
| +2% | +$256K | 0.16% | 149 |
|
|
2018
Q1 | $14.8M | Buy |
90,583
+701
| +0.8% | +$115K | 0.15% | 146 |
|
|
2017
Q4 | $13.5M | Buy |
89,882
+11,489
| +15% | +$1.7M | 0.14% | 164 |
|
|
2017
Q3 | $11.9M | Buy |
78,393
+10,743
| +16% | +$1.62M | 0.13% | 170 |
|
|
2017
Q2 | $8.64M | Buy |
67,650
+650
| +1% | +$78.2K | 0.1% | 214 |
|
|
2017
Q1 | $7.33M | Buy |
67,000
+6,315
| +10% | +$556K | 0.09% | 245 |
|
|
2016
Q4 | $4.47M | Sell |
60,685
-1,190
| -2% | -$96.8K | 0.05% | 346 |
|
|
2016
Q3 | $5.4M | Sell |
61,875
-1,500
| -2% | -$142K | 0.07% | 297 |
|
|
2016
Q2 | $5.45M | Buy |
63,375
+11,375
| +22% | +$983K | 0.07% | 284 |
|
|
2016
Q1 | $4.13M | Sell |
52,000
-2,300
| -4% | -$208K | 0.06% | 335 |
|
|
2015
Q4 | $6.83M | Buy |
54,300
+4,100
| +8% | +$495K | 0.1% | 209 |
|
|
2015
Q3 | $5.33M | Buy |
50,200
+50
| +0.1% | +$6.42K | 0.08% | 253 |
|
|
2015
Q2 | $6.19M | Sell |
50,150
-2,800
| -5% | -$353K | 0.09% | 226 |
|
|
2015
Q1 | $6.25M | Sell |
52,950
-700
| -1% | -$83.9K | 0.09% | 234 |
|
|
2014
Q4 | $6.37M | Sell |
53,650
-300
| -0.6% | -$33.8K | 0.09% | 230 |
|
|
2014
Q3 | $6.06M | Sell |
53,950
-500
| -0.9% | -$47.6K | 0.08% | 230 |
|
|
2014
Q2 | $5.16M | Sell |
54,450
-4,800
| -8% | -$337K | 0.07% | 264 |
|
|
2014
Q1 | $4.19M | Buy |
59,250
+4,900
| +9% | +$388K | 0.06% | 321 |
|
|
2013
Q4 | $4.04M | Sell |
54,350
-1,800
| -3% | -$125K | 0.06% | 317 |
|
|
2013
Q3 | $4.26M | Sell |
56,150
-100
| -0.2% | -$7.96K | 0.07% | 287 |
|
|
2013
Q2 | $4.5M | Buy |
+56,250
| New | +$4.14M | 0.07% | 255 |
|
Other funds holding VRTX
VCM
VPM
Nisa Investment Advisors's VRTX Position: Q1 2026 in Review
Nisa Investment Advisors increased its Vertex Pharmaceuticals (VRTX) stake by 2.8% in Q1 2026, buying an estimated $741K and bringing the position to 58,183 shares worth $26M. The position accounts for 0.1% of the portfolio, ranked #133.
Nisa Investment Advisors first reported a position in VRTX in Q2 2013 and has held it in 52 quarters since. The position peaked at $37.8M in Q2 2020. 1,691 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.
- Nisa Investment Advisors held 58,183 shares of Vertex Pharmaceuticals worth $26M as of Q1 2026.
- Nisa Investment Advisors bought 1,589 Vertex Pharmaceuticals shares in Q1 2026, an estimated $741K.
- Vertex Pharmaceuticals made up 0.1% of Nisa Investment Advisors's portfolio in Q1 2026, its #133 holding.
- Nisa Investment Advisors first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- Nisa Investment Advisors's Vertex Pharmaceuticals position peaked at $37.8M in Q2 2020.
- 1,691 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.
Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.